Generic placeholder image

Current Women`s Health Reviews

Editor-in-Chief

ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Systematic Review Article

The Effect of Melissa officinalis on Premenstrual Syndrome and Primary Dysmenorrhea in Women of Reproductive Age: A Systematic Review and Meta-Analysis

Author(s): Mahsa Maghalian, Mojgan Mirghafourvand* and Nafiseh Ghassab-Abdollahi

Volume 18, Issue 3, 2022

Published on: 07 January, 2022

Article ID: e310821196001 Pages: 12

DOI: 10.2174/1573404817666210831165630

Price: $65

Abstract

Background: Premenstrual syndrome (PMS) and dysmenorrhea are prevalent disabling conditions and affecting the quality of life of women of reproductive age. Melissa officinalis exhibits multiple pharmacological properties, including anti-inflammatory, antispasmodic, analgesic, and antidepressant activities.

Objective: The aim of this study was to systematically review the effect of Melissa officinalis on PMS and primary dysmenorrhea.

Methods: A systematic search in English (Embase ،PubMed, ProQuest, Scopus, Clininaltrial.gov, Cochrane Library), and Persian (SID, Magiran, Iran Doc) databases to find articles was carried out in May 2020. All types of clinical trials were included. Two authors independently selected the articles and quality assessments and extracted the data. Standardized Mean Difference (SMD) was described as a measure of effect size due to the application of multiple tools to measure the severity of PMS. The quality of evidence was assessed using the GRADE approach.

Results: A total of 978 articles were obtained from databases. Ultimately, 7 articles were included in the study. Based on the results of these 7 studies, the consumption of Melissa officinalis improved the symptoms of PMS and primary dysmenorrhea after treatment, as compared to the control group. Also, from the meta-analysis results, the consumption of Melissa officinalis in the intervention group as compared to the control group, significantly reduced the mean severity of PMS's symptoms following treatment) SMD: -0.93; 95% CI: -.19 to -0.67; P=0. 88; I2=0%).

Conclusion: Due to the limited number of articles included in the meta-analysis, conducting well- designed clinical trials with large sample size to ascertain the effect of Melissa officinalis on PMS and primary dysmenorrhea are recommended.

Keywords: Lemon balm, dysmenorrhea, premenstrual syndrome, herbal medicine, systematic review, meta-analysis.

Graphical Abstract

[1]
Kwan I, Onwude JL. Premenstrual syndrome. BMJ Clin Evid 2015; 2015: 0806.
[2]
Chin LN, Nambiar S. Management of premenstrual syndrome. Obstetrics Gynaecol Reprod Med 2017; 27(1): 1-6.
[http://dx.doi.org/10.1016/j.ogrm.2016.11.003]
[3]
Direkvand Moghadam A, Kaikhavani S, Sayehmiri K. The worldwide prevalence of premenstrual syndrome: a systematic review and meta-analysis study. Majallah-i Zanan, Mamai va Nazai-i Iran 2013; 6(65): 8-17. http://ijogi.mums.ac.ir/article_1877.html
[4]
Ranjbaran M, Samani RO, Almasi-Hashiani A, Matourypour P, Moini A. Prevalence of premenstrual syndrome in iran: a systematic review and meta-analysis. Int J Reprod Biomed 2017; 15(11): 686.: 679.
[http://dx.doi.org/10.29252/ijrm.15.11.679]
[5]
Del Mar Fernández M, Regueira-Méndez C, Takkouche B. Psychological factors and premenstrual syndrome: A Spanish case- control study. PLoS One 2019; 14(3): e0212557.
[http://dx.doi.org/10.1371/journal.pone.0212557] [PMID: 30840651]
[6]
Liu Q, Wang Y, van Heck CH, Qiao W. Stress reactivity and emotion in premenstrual syndrome. Neuropsychiatr Dis Treat 2017; 13: 1597-602.
[http://dx.doi.org/10.2147/NDT.S132001] [PMID: 28670129]
[7]
Cao S, Jones M, Tooth L, Mishra GD. History of premenstrual syndrome and development of postpartum depression: A systematic review and meta-analysis. J Psychiatr Res 2020; 121: 82-90.
[http://dx.doi.org/10.1016/j.jpsychires.2019.11.010] [PMID: 31783236]
[8]
Bianco V, Cestari AM, Casati D, Cipriani S, Radici G, Valente I. Premenstrual syndrome and beyond: lifestyle, nutrition, and personal facts. Minerva Ginecol 2014; 66(4): 365-75.
[PMID: 25020055]
[9]
Lefebvre G, Pinsonneault O, Antao V, et al. Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can 2005; 27(12): 1117-46.
[http://dx.doi.org/10.1016/S1701-2163(16)30395-4] [PMID: 16524531]
[10]
Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ 2006; 332(7550): 1134-8.
[http://dx.doi.org/10.1136/bmj.332.7550.1134] [PMID: 16690671]
[11]
Kharaghani R, Damghanian M. The prevalence of dysmenorrhea in iran: a systematic review and meta-analysis. Iran Red Crescent Med J 2016; 19(3): e40856.
[http://dx.doi.org/10.5812/ircmj.40856]
[12]
Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 2015; 21(6): 762-78.
[http://dx.doi.org/10.1093/humupd/dmv039] [PMID: 26346058]
[13]
Sharghi M, Mansurkhani SM, Larky DA, et al. An update and systematic review on the treatment of primary dysmenorrhea. JBRA Assist Reprod 2019; 23(1): 51-7.
[http://dx.doi.org/10.5935/1518-0557.20180083] [PMID: 30521155]
[14]
Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci 2013; 16(5): 821-47.
[http://dx.doi.org/10.18433/J3VW2F] [PMID: 24393558]
[15]
Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev 2006; 4(4): CD006034.
[http://dx.doi.org/10.1002/14651858.CD006034.pub2] [PMID: 17054271]
[16]
Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability Prim. Care Companion. J Clin Psychiatry 2001; 3(1): 22-7.
[http://dx.doi.org/10.4088/PCC.v03n0105] [PMID: 15014625]
[17]
Zeraati F, Shobeiri F, Nazari M, Araghchian M, Bekhradi R. Comparative evaluation of the efficacy of herbal drugs (fennelin and vitagnus) and mefenamic acid in the treatment of primary dysmenorrhea. Iran J Nurs Midwifery Res 2014; 19(6): 581-4.
[PMID: 25558254]
[18]
Yu A. Complementary and alternative treatments for primary dysmenorrhea in adolescents. Nurse Pract 2014; 39(11): 1-12.
[http://dx.doi.org/10.1097/01.NPR.0000454984.19413.28] [PMID: 25325520]
[19]
Fisher C, Adams J, Hickman L, Sibbritt D. The use of complementary and alternative medicine by 7427 Australian women with cyclic perimenstrual pain and discomfort: a cross-sectional study. BMC Complement Altern Med 2016; 16(1): 129.
[http://dx.doi.org/10.1186/s12906-016-1119-8] [PMID: 27189381]
[20]
Ulbricht C, Brendler T, Gruenwald J, et al. Lafferty, Catherine Ulbricht, PharmD, MBA (C), Column editor lemon balm (Melissa officinalis l.) an evidence-based systematic review by the natural standard research collaboration. . J Herb Pharmacother 2005; 5(4): 71-114.
[http://dx.doi.org/10.1080/J157v05n04_08] [PMID: 16635970]
[21]
Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. - a review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 2016; 188: 204-28.
[http://dx.doi.org/10.1016/j.jep.2016.05.010] [PMID: 27167460]
[22]
Zarei A, Changizi-Ashtiyani S, Taheri S, Hosseini N. A brief overview of the effects of Melissa officinalis l. extract on the function of various body organs. Zahedan J Res Med Sci 2015; 17(7): 1-6.
[http://dx.doi.org/10.17795/zjrms1007]
[23]
Bounihi A, Hajjaj G, Alnamer R, Cherrah Y, Zellou A. in vivo potential anti-inflammatory activity of Melissa officinalis l. essential oil. Adv Pharmacol Sci 2013; 2013: 101759.
[http://dx.doi.org/10.1155/2013/101759] [PMID: 24381585]
[24]
Lin SH, Chou ML, Chen WC, et al. A medicinal herb, Melissa officinalis l. ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitter. J Ethnopharmacol 2015; 175: 266-72.
[http://dx.doi.org/10.1016/j.jep.2015.09.018] [PMID: 26408043]
[25]
Higgins J, Wells G. Cochrane handbook for systematic reviews of interventions. 2011.
[26]
Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
[http://dx.doi.org/10.1136/bmj.d5928] [PMID: 22008217]
[27]
Kalvandi R, Alimohammadi S, Pashmakian Z, Rajabi M. The effects of medicinal plants of Melissa officinalis and salvia officinalis on primary dysmenorrhea. Sci J Hamadan Univ Med Sci 2014; 21(2): 105-11.
[28]
Ghanbari-Homayi S, Mirghafourvand M, Torbati M. The efficacy of lemon balm and combination of lemon balm and nepeta menthoides in menstrual bleeding among students with premenstrual syndrome: a randomized controlled trial. Iran Red Crescent Med J 2016; 18(12): e28941.
[http://dx.doi.org/10.5812/ircmj.28941]
[29]
Akbarzadeh M, Dehghani M, Moshfeghy Z, Emamghoreishi M, Tavakoli P, Zare N. Effect of Melissa officinalis capsule on the intensity of premenstrual syndrome symptoms in high school girl students. Nurs Midwifery Stud 2015; 4(2): e27001.
[http://dx.doi.org/10.17795/nmsjournal27001] [PMID: 26339667]
[30]
Heydari N, Dehghani M, Emamghoreishi M, Akbarzadeh M. Effect of Melissa officinalis capsule on the mental health of female adolescents with premenstrual syndrome: a clinical trial study. Int J Adolesc Med Health 2018; 31(3): 2015-7.
[http://dx.doi.org/10.1515/ijamh-2017-0015] [PMID: 29369810]
[31]
Mirabi P, Alamolhoda SH, Yazdkhasti M, Mojab F. The effects of lemon balm on menstrual bleeding and the systemic manifestation of dysmenorrhea. Iran J Pharm Res 2018; 17(Suppl. 2): 214-23.
[PMID: 31011354]
[32]
Mirabi P, Namdari M, Alamolhoda S, Mojab F. The effect of Melissa officinalis extract on the severity of primary dysmenorrha. Iran J Pharm Res 2017; 16: 171-7.
[PMID: 29844788]
[33]
Safdari Dehcheshmeh F, Parvin N. The effect of mefenamic acid and Melissa officinalis on primary dysmenorrhea: a randomized clinical trial study. Int J Pharmacogn Phytochem Res 2016; 8(8): 1286-92.
[34]
Mirghafourvand M, Malakouti J, Charandabi SMA, Khalili AF, Homayi SG. The efficacy of lemon balm (Melissa officinalis l.) alone and combined with lemon balm—nepeta menthoides on premenstrual syndrome and quality of life among students: a randomized controlled trial. J Herb Med 2016; 6(3): 142-8.
[http://dx.doi.org/10.1016/j.hermed.2016.07.001]
[35]
Akbarzadeh M, Moshfeghy Z, Dehghani M, Emamghoreishi M, Tavakoli P, Zare N. Comparison of the effect of Melissa officinalis capsule and care educational programs on the intensity of physical, mental and social symptoms of premenstrual syndrome in high school female students. Int J Womens Health 2018; 6(1): 18-26.
[http://dx.doi.org/10.15296/ijwhr.2018.05]
[36]
[37]
Rajabzadeh F, Fazljou SM, Khodaie L, Abbasalizadeh S, Sahebi L. Effects of hot temperament herbs on primary dysmenorrhea: a systematic review. Middle East J Fam Med 2018; 16(3): 257-63.
[http://dx.doi.org/10.5742/MEWFM.2018.93338]
[38]
Maleki-Saghooni N, Karimi FZ, Behboodi Moghadam Z, Mirzaii Najmabadi K. The effectiveness and safety of Iranian herbal medicines for treatment of premenstrual syndrome: A systematic review. Avicenna J Phytomed 2018; 8(2): 96-113.
[PMID: 29632841]
[39]
Rastegarian A, Abedi H, Jahromi HK, et al. Analgesic effect of intrathecal Melissa officinalis in the rat model of hot-water and formalin-induced pain. J Acupunct Meridian Stud 2020; 13(1): 19-24.
[http://dx.doi.org/10.1016/j.jams.2019.11.001] [PMID: 31743772]
[40]
Naderi Dastjerdi M, Darooneh T, Nasiri M, Moatar F, Esmaeili S, Ozgoli G. Investigating the effect of Melissa officinalis on after- pains: a randomized single-blind clinical trial. J Caring Sci 2019; 8(3): 129-35.
[http://dx.doi.org/10.15171/jcs.2019.019] [PMID: 31598505]
[41]
Guginski G, Luiz AP, Silva MD, et al. Mechanisms involved in the antinociception caused by ethanolic extract obtained from the leaves of Melissa officinalis (lemon balm) in mice. Pharmacol Biochem Behav 2009; 93(1): 10-6.
[http://dx.doi.org/10.1016/j.pbb.2009.03.014] [PMID: 19358864]
[42]
Jones PG, Dunlop J. Targeting the cholinergic system as a therapeutic strategy for the treatment of pain. Neuropharmacology 2007; 53(2): 197-206.
[http://dx.doi.org/10.1016/j.neuropharm.2007.04.002] [PMID: 17543355]
[43]
Savino F, Cresi F, Castagno E, Silvestro L, Oggero R. A randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis (ColiMil) in the treatment of breastfed colicky infants. Phytother Res 2005; 19(4): 335-40.
[http://dx.doi.org/10.1002/ptr.1668] [PMID: 16041731]
[44]
Sadraei H, Ghannadi A, Malekshahi K. Relaxant effect of essential oil of Melissa officinalis and citral on rat ileum contractions. Fitoterapia 2003; 74(5): 445-52.
[http://dx.doi.org/10.1016/S0367-326X(03)00109-6] [PMID: 12837359]
[45]
Emamghoreishi M, Talebianpour M. Antidepressant effect of Melissa officinalis in the forced swimming test. Daru 2015; 17(1): 42-7.
[46]
Asadi A, Shidfar F, Safari M, et al. Safety and efficacy of Melissa officinalis (lemon balm) on ApoA-I, Apo B, lipid ratio and ICAM-1 in type 2 diabetes patients: A randomized, double-blinded clinical trial. Complement Ther Med 2018; 40: 83-8.
[http://dx.doi.org/10.1016/j.ctim.2018.07.015] [PMID: 30219475]
[47]
Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med 2004; 66(4): 607-13.
[http://dx.doi.org/10.1097/01.psy.0000132877.72833.71] [PMID: 15272110]
[48]
Müller SF, Klement S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine 2006; 13(6): 383-7.
[http://dx.doi.org/10.1016/j.phymed.2006.01.013] [PMID: 16487692]
[49]
Noguchi-Shinohara M, Ono K, Hamaguchi T, et al. Pharmacokinetics, safety and tolerability of Melissa officinalis extract which contained rosmarinic acid in healthy individuals: a randomized controlled trial. PLoS One 2015; 10(5): e0126422.
[http://dx.doi.org/10.1371/journal.pone.0126422] [PMID: 25978046]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy